Scholar

3min
Google Scholar Results
﻿DESKTOP TABLET MOBILE 
Scale SERP parses the Google scholar search results the scholar_results array in the JSON output when the  search_type=scholar  search parameter is set.
Google Image Results
﻿
Below is an example of how the scholar_results array is represented in the Scale SERP result JSON:
JSON
{
  "request_info": {
    "success": true,
    "credits_used": 1,
    "credits_used_this_request": 1,
    "credits_remaining": 19999,
    "credits_reset_at": "2021-01-01T00:00:00.000Z"
  },
  "search_metadata": {
    "created_at": "2021-01-01T00:00:00.000Z",
    "processed_at": "2021-01-01T00:00:00.000Z",
    "total_time_taken": 1.5,
    "engine_url": "https://www.google.com/scholar?q=rubifen",
    "html_url": "https://api.scaleserp.com/search?api_key=APIKEY&q=rubifen&location=United+States&search_type=scholar&engine=google&output=html",
    "json_url": "https://api.scaleserp.com/search?api_key=APIKEY&q=rubifen&location=United+States&search_type=scholar&engine=google&output=json"
  },
  "search_parameters": {
    "q": "rubifen",
    "location": "United States",
    "search_type": "scholar",
    "engine": "google"
  },
  "search_information": {
    "original_query_yields_zero_results": false,
    "query_displayed": "rubifen"
  },
  "scholar_results": [
    {
      "position": 1,
      "title": "[PDF][PDF] fárMaco de prueba",
      "link": "http://www.pharmavita.cl/wp-content/uploads/2014/09/Brochure_RubifenPortada.pdf",
      "domain": "www.pharmavita.cl",
      "displayed_link": "I VIVo - pharmavita.cl",
      "snippet": "… RuBIFEN® (Metilfenidato) puede ad- ministrarse tanto en presencia como en ausencia de\nalimentos junto con líquido … nota: puede ser conveniente suspender periódicamente el\ntratamiento con RuBI- FEN® (Metilfenidato) para evaluar el estado del niño",
      "cited_by_count": 188,
      "cited_by_link": "https://www.google.com/scholar?cites=2865832699770200924&as_sdt=2005&sciodt=0,5&hl=fr",
      "pdf_link": "https://diabetesjournals.org/diabetes/article-pdf/62/10/3307/569495/3307.pdf",
      "versions_count": 4,
      "versions_link": "https://www.google.com/scholar?cluster=2865832699770200924&hl=fr&as_sdt=0,5"
    },
    {
      "position": 2,
      "title": "[HTML][HTML] MEDICINES ADVERSE REACTIONS COMMITTEE 20 March 2008 MEETING MINUTES",
      "link": "https://medsafe.govt.nz/profs/adverse/Minutes133.htm",
      "domain": "medsafe.govt.nz",
      "displayed_link": "T Maling, H Kingston, F McClure, D Reith, L Bryant… - medsafe.govt.nz",
      "snippet": "… 2.1.2 Rubifen SR (methylphenidate SR) brand switch - aggressive and defiant behavioural\nreactions December 2007 minute item 2.1.2, September 2007 minute item 3.2. Issue … Medsafe\nsought further information from the Rubifen product sponsor including the following",
      "cited_by_count": 188,
      "cited_by_link": "https://www.google.com/scholar?cites=2865832699770200924&as_sdt=2005&sciodt=0,5&hl=fr",
      "versions_count": 4,
      "versions_link": "https://www.google.com/scholar?cluster=2865832699770200924&hl=fr&as_sdt=0,5"
    },
    {
      "position": 3,
      "title": "Análisis de minimización de costes y del impacto sobre el presupuesto del Sistema Nacional de Salud del tratamiento del trastorno por déficit de atención con …",
      "link": "https://link.springer.com/content/pdf/10.1007/BF03320877.pdf",
      "domain": "link.springer.com",
      "displayed_link": "C Rubio-Terrés, D Rubio-Rodríguez… - … Spanish Research Articles, 2012 - Springer",
      "snippet": "… Resumen Introducción: No hay evidencia científica de diferencias significativas de efi- cacia\no tolerabilidad entre el metilfenidato de liberación inmediata (MLI; Rubifen®) y el de liberación\nprolongada (MLP; Medikinet®, Concerta®) en el tratamiento del trastorno por déficit de",
      "cited_by_count": 188,
      "cited_by_link": "https://www.google.com/scholar?cites=2865832699770200924&as_sdt=2005&sciodt=0,5&hl=fr",
      "versions_count": 4,
      "versions_link": "https://www.google.com/scholar?cluster=2865832699770200924&hl=fr&as_sdt=0,5"
    },
    {
      "position": 4,
      "title": "El impacto de la rehabilitación neuropsicológica en niños con TDAH",
      "link": "http://dehesa.unex.es/handle/10662/6497",
      "domain": "dehesa.unex.es",
      "displayed_link": "AF Rodrigues - 2017 - dehesa.unex.es",
      "snippet": "… La elección del tratamiento para el TDAH es la terapia de medicamentos, más específicamente\nmetilfenidato. Este componente se coloca en el mercado con los nombres comerciales de Ritalin\ny Rubifen … This component is marketed under the trade names Ritalin and Rubifen",
      "cited_by_count": 188,
      "cited_by_link": "https://www.google.com/scholar?cites=2865832699770200924&as_sdt=2005&sciodt=0,5&hl=fr",
      "versions_count": 4,
      "versions_link": "https://www.google.com/scholar?cluster=2865832699770200924&hl=fr&as_sdt=0,5"
    },
    {
      "position": 5,
      "title": "[PDF][PDF] Correlación electroclínica diagnóstica y terapéutica con metilfenidato de acción inmediata en TDAH",
      "link": "https://www.seinap.es/wp-content/uploads/Revista-de-Pediatria/2004/REP%2060-3.pdf#page=7",
      "domain": "www.seinap.es",
      "displayed_link": "JRV Usón - ás se rna, 2004 - seinap.es",
      "snippet": "… la respuesta clínica. Con estos parámetros, las dosis de MPH de liberación inmediata\n(Rubifen®) que se administraron fueron entre 10 a 40 mg, repartidas en el desayuno\ny la comida, según ne- cesidad clínica. Dentro de la"
    },
    {
      "position": 6,
      "title": "Metilfenidato: actualización de las condiciones de uso:(Nota informativa de la AEMPS 2009/01, de 22 de enero de 2009)",
      "link": "https://dialnet.unirioja.es/servlet/articulo?codigo=2961760",
      "domain": "dialnet.unirioja.es",
      "displayed_link": "LG Juan - Actualidad en farmacología y terapéutica, 2009 - dialnet.unirioja.es",
      "snippet": "… En nuestro país, el metilfenidato está comercializado como formulaciones de liberación inmediata\n(Rubifen®) y de liberación prolongada (Concerta® y Medikinet cápsulas®). Fundación Dialnet.\nAcceso de usuarios registrados. Identificarse ¿Olvidó su contraseña? ¿Es nuevo"
    },
    {
      "position": 7,
      "title": "[PDF][PDF] ESTADO ACTUAL DEL ENFOQUE DEL TDAH EN NEUROPEDIATRIA",
      "link": "https://eventos.emagister.com/_files/_event/_7507/_editorFiles/file/pon/CARDO,%20ESTHER.pdf",
      "domain": "eventos.emagister.com",
      "displayed_link": "E Cardo, G Ros, J Eiris, C Escofet, A Fernández-Jaén… - eventos.emagister.com",
      "snippet": "… respecto a la medicación utilizada, la mayoría de los pacientes se encontraban bajo tratamiento\ncon algún tipo de metilfenidato de liberación prolongada (Equasym©, Medikinet© o Concerta©),\nun porcentaje estable utilizaban Metilfenidato de liberación inmediata (Rubifen"
    },
    {
      "position": 8,
      "title": "Implicación del farmacéutico comunitario en la dispensación a pacientes con trastorno por déficit de atención e hiperactividad. Un estudio piloto",
      "link": "http://pharmcareesp.com/index.php/PharmaCARE/article/view/88",
      "domain": "pharmcareesp.com",
      "displayed_link": "MD Palomino, MJ Martín-Calero… - Pharmaceutical Care …, 2012 - pharmcareesp.com",
      "snippet": "… Metilfenidato de liberación inmediata Rubifen® 5, 10, 20 mg Comprimidos de liberación inmediata\n2-3 veces al día Dosis de inicio: 5 mg Incrementos semanales de 5 mg/toma (hasta ajustar la\ndosis) Dosis diaria ≤60 mg Efecto inmediato, duración de 2-4 h tras cada toma"
    },
    {
      "position": 9,
      "title": "Effect of switching drug formulations from immediate-release to extended-release OROS Methylphenidate",
      "link": "https://link.springer.com/article/10.2165/00023210-200822070-00005",
      "domain": "link.springer.com",
      "displayed_link": "JA Ramos-Quiroga, R Bosch, X Castells, S Valero… - CNS drugs, 2008 - Springer",
      "snippet": "… Abstract. Background: The potential advantages of osmotic-release oral system (OROS)\nmethylphenidate (Concerta®) over immediate-release (IR) methylphenidate (Rubifen®) in adults\nwith attention-deficit hyperactivity disorder (ADHD), with respect to medication adherence"
    },
    {
      "position": 10,
      "title": "The impact of psychopedagogical intervention on quality of life in adolescents with attention deficit hyperactivity disorder (ADHD) treated with psychostimulant …",
      "link": "https://www.cambridge.org/core/journals/european-psychiatry/article/impact-of-psychopedagogical-intervention-on-quality-of-life-in-adolescents-with-attention-deficit-hyperactivity-disorder-adhd-treated-with-psychostimulant-medication/76422BADEBE6B6BD3687DE0B51358A81",
      "domain": "www.cambridge.org",
      "displayed_link": "C Lima, D Rodrigues, M Silva, S Rego - European Psychiatry, 2017 - cambridge.org",
      "snippet": "… plans. The aim of this study was to evaluate the impact of a psychopedagogical\nintervention on quality of life of a sample of adolescents with ADHD taking into account\ntheir pharmacologi- cal plans (rubifen, ritalin, and concerta)"
    }
  ],
  "pagination": {
    "current": 1,
    "next": "https://www.google.com/scholar?start=10&q=rubifen&hl=en&as_sdt=0,48",
    "other_pages": [
      {
        "page": 2,
        "link": "https://www.google.com/scholar?start=10&q=rubifen&hl=en&as_sdt=0,48"
      },
      {
        "page": 3,
        "link": "https://www.google.com/scholar?start=20&q=rubifen&hl=en&as_sdt=0,48"
      }
    ],
    "api_pagination": {
      "next": "https://api.scaleserp.com/search?api_key=APIKEY&q=rubifen&location=United%20States&search_type=scholar&engine=google&page=2",
      "other_pages": [
        {
          "page": 2,
          "link": "https://api.scaleserp.com/search?api_key=APIKEY&q=rubifen&location=United%20States&search_type=scholar&engine=google&page=2"
        },
        {
          "page": 3,
          "link": "https://api.scaleserp.com/search?api_key=APIKEY&q=rubifen&location=United%20States&search_type=scholar&engine=google&page=3"
        }
      ]
    }
  },
  "related_searches": [
    {
      "query": "text network analysis nursing",
      "link": "https://www.google.com/scholar?hl=fr&as_sdt=0,5&qsp=1&q=text+network+analysis+nursing&qst=ib",
      "type": "standard"
    },
    {
      "query": "text network analysis gephi",
      "link": "https://www.google.com/scholar?hl=fr&as_sdt=0,5&qsp=2&q=text+network+analysis+gephi&qst=ib",
      "type": "standard"
    },
    {
      "query": "text network analysis corpus studies",
      "link": "https://www.google.com/scholar?hl=fr&as_sdt=0,5&qsp=3&q=text+network+analysis+corpus+studies&qst=ib",
      "type": "standard"
    },
    {
      "query": "text network analysis knowledge structure",
      "link": "https://www.google.com/scholar?hl=fr&as_sdt=0,5&qsp=4&q=text+network+analysis+knowledge+structure&qst=ib",
      "type": "standard"
    },
    {
      "query": "text network analysis discourse bias",
      "link": "https://www.google.com/scholar?hl=fr&as_sdt=0,5&qsp=5&q=text+network+analysis+discourse+bias&qst=ib",
      "type": "standard"
    },
    {
      "query": "text network analysis centrality",
      "link": "https://www.google.com/scholar?hl=fr&as_sdt=0,5&qsp=6&q=text+network+analysis+centrality&qst=ib",
      "type": "standard"
    },
    {
      "query": "text network analysis public administration",
      "link": "https://www.google.com/scholar?hl=fr&as_sdt=0,5&qsp=7&q=text+network+analysis+public+administration&qst=ib",
      "type": "standard"
    },
    {
      "query": "text network analysis kapucu",
      "link": "https://www.google.com/scholar?hl=fr&as_sdt=0,5&qsp=8&q=text+network+analysis+kapucu&qst=ib",
      "type": "standard"
    }
  ]
}
{
  "request_info": {
    "success": true,
    "credits_used": 1,
    "credits_used_this_request": 1,
    "credits_remaining": 19999,
    "credits_reset_at": "2021-01-01T00:00:00.000Z"
  },
  "search_metadata": {
    "created_at": "2021-01-01T00:00:00.000Z",
    "processed_at": "2021-01-01T00:00:00.000Z",
    "total_time_taken": 1.5,
    "engine_url": "https://www.google.com/scholar?q=rubifen",
    "html_url": "https://api.scaleserp.com/search?api_key=APIKEY&q=rubifen&location=United+States&search_type=scholar&engine=google&output=html",
    "json_url": "https://api.scaleserp.com/search?api_key=APIKEY&q=rubifen&location=United+States&search_type=scholar&engine=google&output=json"
  },
  "search_parameters": {
    "q": "rubifen",
    "location": "United States",
    "search_type": "scholar",
    "engine": "google"
  },
  "search_information": {
    "original_query_yields_zero_results": false,
    "query_displayed": "rubifen"
  },
  "scholar_results": [
    {
      "position": 1,
      "title": "[PDF][PDF] fárMaco de prueba",
      "link": "http://www.pharmavita.cl/wp-content/uploads/2014/09/Brochure_RubifenPortada.pdf",
      "domain": "www.pharmavita.cl",
      "displayed_link": "I VIVo - pharmavita.cl",
      "snippet": "… RuBIFEN® (Metilfenidato) puede ad- ministrarse tanto en presencia como en ausencia de\nalimentos junto con líquido … nota: puede ser conveniente suspender periódicamente el\ntratamiento con RuBI- FEN® (Metilfenidato) para evaluar el estado del niño",
      "cited_by_count": 188,
      "cited_by_link": "https://www.google.com/scholar?cites=2865832699770200924&as_sdt=2005&sciodt=0,5&hl=fr",
      "pdf_link": "https://diabetesjournals.org/diabetes/article-pdf/62/10/3307/569495/3307.pdf",
      "versions_count": 4,
      "versions_link": "https://www.google.com/scholar?cluster=2865832699770200924&hl=fr&as_sdt=0,5"
    },
    {
      "position": 2,
      "title": "[HTML][HTML] MEDICINES ADVERSE REACTIONS COMMITTEE 20 March 2008 MEETING MINUTES",
      "link": "https://medsafe.govt.nz/profs/adverse/Minutes133.htm",
      "domain": "medsafe.govt.nz",
      "displayed_link": "T Maling, H Kingston, F McClure, D Reith, L Bryant… - medsafe.govt.nz",
      "snippet": "… 2.1.2 Rubifen SR (methylphenidate SR) brand switch - aggressive and defiant behavioural\nreactions December 2007 minute item 2.1.2, September 2007 minute item 3.2. Issue … Medsafe\nsought further information from the Rubifen product sponsor including the following",
      "cited_by_count": 188,
      "cited_by_link": "https://www.google.com/scholar?cites=2865832699770200924&as_sdt=2005&sciodt=0,5&hl=fr",
      "versions_count": 4,
      "versions_link": "https://www.google.com/scholar?cluster=2865832699770200924&hl=fr&as_sdt=0,5"
    },
    {
      "position": 3,
      "title": "Análisis de minimización de costes y del impacto sobre el presupuesto del Sistema Nacional de Salud del tratamiento del trastorno por déficit de atención con …",
      "link": "https://link.springer.com/content/pdf/10.1007/BF03320877.pdf",
      "domain": "link.springer.com",
      "displayed_link": "C Rubio-Terrés, D Rubio-Rodríguez… - … Spanish Research Articles, 2012 - Springer",
      "snippet": "… Resumen Introducción: No hay evidencia científica de diferencias significativas de efi- cacia\no tolerabilidad entre el metilfenidato de liberación inmediata (MLI; Rubifen®) y el de liberación\nprolongada (MLP; Medikinet®, Concerta®) en el tratamiento del trastorno por déficit de",
      "cited_by_count": 188,
      "cited_by_link": "https://www.google.com/scholar?cites=2865832699770200924&as_sdt=2005&sciodt=0,5&hl=fr",
      "versions_count": 4,
      "versions_link": "https://www.google.com/scholar?cluster=2865832699770200924&hl=fr&as_sdt=0,5"
    },
    {
      "position": 4,
      "title": "El impacto de la rehabilitación neuropsicológica en niños con TDAH",
      "link": "http://dehesa.unex.es/handle/10662/6497",
      "domain": "dehesa.unex.es",
      "displayed_link": "AF Rodrigues - 2017 - dehesa.unex.es",
      "snippet": "… La elección del tratamiento para el TDAH es la terapia de medicamentos, más específicamente\nmetilfenidato. Este componente se coloca en el mercado con los nombres comerciales de Ritalin\ny Rubifen … This component is marketed under the trade names Ritalin and Rubifen",
      "cited_by_count": 188,
      "cited_by_link": "https://www.google.com/scholar?cites=2865832699770200924&as_sdt=2005&sciodt=0,5&hl=fr",
      "versions_count": 4,
      "versions_link": "https://www.google.com/scholar?cluster=2865832699770200924&hl=fr&as_sdt=0,5"
    },
    {
      "position": 5,
      "title": "[PDF][PDF] Correlación electroclínica diagnóstica y terapéutica con metilfenidato de acción inmediata en TDAH",
      "link": "https://www.seinap.es/wp-content/uploads/Revista-de-Pediatria/2004/REP%2060-3.pdf#page=7",
      "domain": "www.seinap.es",
      "displayed_link": "JRV Usón - ás se rna, 2004 - seinap.es",
      "snippet": "… la respuesta clínica. Con estos parámetros, las dosis de MPH de liberación inmediata\n(Rubifen®) que se administraron fueron entre 10 a 40 mg, repartidas en el desayuno\ny la comida, según ne- cesidad clínica. Dentro de la"
    },
    {
      "position": 6,
      "title": "Metilfenidato: actualización de las condiciones de uso:(Nota informativa de la AEMPS 2009/01, de 22 de enero de 2009)",
      "link": "https://dialnet.unirioja.es/servlet/articulo?codigo=2961760",
      "domain": "dialnet.unirioja.es",
      "displayed_link": "LG Juan - Actualidad en farmacología y terapéutica, 2009 - dialnet.unirioja.es",
      "snippet": "… En nuestro país, el metilfenidato está comercializado como formulaciones de liberación inmediata\n(Rubifen®) y de liberación prolongada (Concerta® y Medikinet cápsulas®). Fundación Dialnet.\nAcceso de usuarios registrados. Identificarse ¿Olvidó su contraseña? ¿Es nuevo"
    },
    {
      "position": 7,
      "title": "[PDF][PDF] ESTADO ACTUAL DEL ENFOQUE DEL TDAH EN NEUROPEDIATRIA",
      "link": "https://eventos.emagister.com/_files/_event/_7507/_editorFiles/file/pon/CARDO,%20ESTHER.pdf",
      "domain": "eventos.emagister.com",
      "displayed_link": "E Cardo, G Ros, J Eiris, C Escofet, A Fernández-Jaén… - eventos.emagister.com",
      "snippet": "… respecto a la medicación utilizada, la mayoría de los pacientes se encontraban bajo tratamiento\ncon algún tipo de metilfenidato de liberación prolongada (Equasym©, Medikinet© o Concerta©),\nun porcentaje estable utilizaban Metilfenidato de liberación inmediata (Rubifen"
    },
    {
      "position": 8,
      "title": "Implicación del farmacéutico comunitario en la dispensación a pacientes con trastorno por déficit de atención e hiperactividad. Un estudio piloto",
      "link": "http://pharmcareesp.com/index.php/PharmaCARE/article/view/88",
      "domain": "pharmcareesp.com",
      "displayed_link": "MD Palomino, MJ Martín-Calero… - Pharmaceutical Care …, 2012 - pharmcareesp.com",
      "snippet": "… Metilfenidato de liberación inmediata Rubifen® 5, 10, 20 mg Comprimidos de liberación inmediata\n2-3 veces al día Dosis de inicio: 5 mg Incrementos semanales de 5 mg/toma (hasta ajustar la\ndosis) Dosis diaria ≤60 mg Efecto inmediato, duración de 2-4 h tras cada toma"
    },
    {
      "position": 9,
      "title": "Effect of switching drug formulations from immediate-release to extended-release OROS Methylphenidate",
      "link": "https://link.springer.com/article/10.2165/00023210-200822070-00005",
      "domain": "link.springer.com",
      "displayed_link": "JA Ramos-Quiroga, R Bosch, X Castells, S Valero… - CNS drugs, 2008 - Springer",
      "snippet": "… Abstract. Background: The potential advantages of osmotic-release oral system (OROS)\nmethylphenidate (Concerta®) over immediate-release (IR) methylphenidate (Rubifen®) in adults\nwith attention-deficit hyperactivity disorder (ADHD), with respect to medication adherence"
    },
    {
      "position": 10,
      "title": "The impact of psychopedagogical intervention on quality of life in adolescents with attention deficit hyperactivity disorder (ADHD) treated with psychostimulant …",
      "link": "https://www.cambridge.org/core/journals/european-psychiatry/article/impact-of-psychopedagogical-intervention-on-quality-of-life-in-adolescents-with-attention-deficit-hyperactivity-disorder-adhd-treated-with-psychostimulant-medication/76422BADEBE6B6BD3687DE0B51358A81",
      "domain": "www.cambridge.org",
      "displayed_link": "C Lima, D Rodrigues, M Silva, S Rego - European Psychiatry, 2017 - cambridge.org",
      "snippet": "… plans. The aim of this study was to evaluate the impact of a psychopedagogical\nintervention on quality of life of a sample of adolescents with ADHD taking into account\ntheir pharmacologi- cal plans (rubifen, ritalin, and concerta)"
    }
  ],
  "pagination": {
    "current": 1,
    "next": "https://www.google.com/scholar?start=10&q=rubifen&hl=en&as_sdt=0,48",
    "other_pages": [
      {
        "page": 2,
        "link": "https://www.google.com/scholar?start=10&q=rubifen&hl=en&as_sdt=0,48"
      },
      {
        "page": 3,
        "link": "https://www.google.com/scholar?start=20&q=rubifen&hl=en&as_sdt=0,48"
      }
    ],
    "api_pagination": {
      "next": "https://api.scaleserp.com/search?api_key=APIKEY&q=rubifen&location=United%20States&search_type=scholar&engine=google&page=2",
      "other_pages": [
        {
          "page": 2,
          "link": "https://api.scaleserp.com/search?api_key=APIKEY&q=rubifen&location=United%20States&search_type=scholar&engine=google&page=2"
        },
        {
          "page": 3,
          "link": "https://api.scaleserp.com/search?api_key=APIKEY&q=rubifen&location=United%20States&search_type=scholar&engine=google&page=3"
        }
      ]
    }
  },
  "related_searches": [
    {
      "query": "text network analysis nursing",
      "link": "https://www.google.com/scholar?hl=fr&as_sdt=0,5&qsp=1&q=text+network+analysis+nursing&qst=ib",
      "type": "standard"
    },
    {
      "query": "text network analysis gephi",
      "link": "https://www.google.com/scholar?hl=fr&as_sdt=0,5&qsp=2&q=text+network+analysis+gephi&qst=ib",
      "type": "standard"
    },
    {
      "query": "text network analysis corpus studies",
      "link": "https://www.google.com/scholar?hl=fr&as_sdt=0,5&qsp=3&q=text+network+analysis+corpus+studies&qst=ib",
      "type": "standard"
    },
    {
      "query": "text network analysis knowledge structure",
      "link": "https://www.google.com/scholar?hl=fr&as_sdt=0,5&qsp=4&q=text+network+analysis+knowledge+structure&qst=ib",
      "type": "standard"
    },
    {
      "query": "text network analysis discourse bias",
      "link": "https://www.google.com/scholar?hl=fr&as_sdt=0,5&qsp=5&q=text+network+analysis+discourse+bias&qst=ib",
      "type": "standard"
    },
    {
      "query": "text network analysis centrality",
      "link": "https://www.google.com/scholar?hl=fr&as_sdt=0,5&qsp=6&q=text+network+analysis+centrality&qst=ib",
      "type": "standard"
    },
    {
      "query": "text network analysis public administration",
      "link": "https://www.google.com/scholar?hl=fr&as_sdt=0,5&qsp=7&q=text+network+analysis+public+administration&qst=ib",
      "type": "standard"
    },
    {
      "query": "text network analysis kapucu",
      "link": "https://www.google.com/scholar?hl=fr&as_sdt=0,5&qsp=8&q=text+network+analysis+kapucu&qst=ib",
      "type": "standard"
    }
  ]
}
﻿
﻿
Scale SERP returns the following properties for  search_type=scholar  requests:
Property
Type
Description
scholar_results
array
An array of Scholar Result objects, containing each of the scholar results returned. The Scholar Result object has the following properties:
position
number
The position of the scholar result on the current page.
﻿
title
string
The title of the scholar result.
﻿
link
string
A link to the scholar result.
﻿
domain
string
The domain of the link to the scholar result.
﻿
displayed_link
string
The displayed (visual) link shown next to the scholar result.
﻿
snippet
string
The snippet text of the scholar result.
﻿
cited_by_count
number
The number of Cites the result has received.
﻿
cited_by_link
string
A Google link to the Cited By results.
﻿
pdf_link
string
A link to the PDF if shown with the result.
﻿
versions_count
number
The number of Versions the result has.
﻿
versions_link
string
A Google link to the Versions results.
pagination
object
An object containing details of the pagination section of the page. Details are provided as Google links and API links (to make sending paginated requests easier):
current
number
The current page number, if shown.
﻿
next
string
The Google URL of the next page of results.
﻿
other_pages
object
An object containing details of the other pages shown on the results page. The object is keyed by the other page number, with the value being the Google URL to the page.
﻿
api_pagination
object
An object containing API links to request the next pages of results. Provided as a convenience to allow you to run subsequent requests for additional pages. Contains a next and other_pages property.
related_searches
array
An array of Related Search objects, containing each of the related searches shown at the bottom of the search results page. The Related Search object has the following properties:
query
string
The keywords / search term of the related search.
﻿
link
string
A link to the Google search URL for the related search.
﻿
Next Steps
     Google Scholar Parameters﻿
Property	Type	Description
scholar_results	array	An array of Scholar Result objects, containing each of the scholar results returned. The Scholar Result object has the following properties: position number The position of the scholar result on the current page. title string The title of the scholar result. link string A link to the scholar result. domain string The domain of the link to the scholar result. displayed_link string The displayed (visual) link shown next to the scholar result. snippet string The snippet text of the scholar result. cited_by_count number The number of Cites the result has received. cited_by_link string A Google link to the Cited By results. pdf_link string A link to the PDF if shown with the result. versions_count number The number of Versions the result has. versions_link string A Google link to the Versions results.
pagination	object	An object containing details of the pagination section of the page. Details are provided as Google links and API links (to make sending paginated requests easier): current number The current page number, if shown. next string The Google URL of the next page of results. other_pages object An object containing details of the other pages shown on the results page. The object is keyed by the other page number, with the value being the Google URL to the page. api_pagination object An object containing API links to request the next pages of results. Provided as a convenience to allow you to run subsequent requests for additional pages. Contains a next and other_pages property.
related_searches	array	An array of Related Search objects, containing each of the related searches shown at the bottom of the search results page. The Related Search object has the following properties: query string The keywords / search term of the related search. link string A link to the Google search URL for the related search.
Updated 14 Aug 2024
Did this page help you?
Videos
Autocomplete